HURWITZ EDWARD

CIK 000121184010 companiesWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001211840

Recent Transactions

50 trades

Award
Dyne Therapeutics, Inc.$DYN
Stock option (right to buy)
2026-06-05+35,152→ 35,152 total
Award
MACROGENICS INC$MGNX
Stock Option (right to buy)
2026-05-19+22,000→ 22,000 total
Award
MACROGENICS INC$MGNX
Restricted Stock Unit
2026-05-19+3,750→ 3,750 total
Exercise/Conversion
MACROGENICS INC$MGNX
Restricted Stock Unit
2026-05-18−3,750→ 0 total
Exercise/Conversion
MACROGENICS INC$MGNX
Common Stock
2026-05-18+3,750→ 47,824 total
Award
Dyne Therapeutics, Inc.$DYN
Stock option (right to buy)
2025-05-30+35,000→ 35,000 total
Award
MACROGENICS INC$MGNX
Restricted Stock Unit
2025-05-21+3,750→ 3,750 total
Award
MACROGENICS INC$MGNX
Stock Option (right to buy)
2025-05-21+22,000→ 22,000 total
Exercise/Conversion
MACROGENICS INC$MGNX
Restricted Stock Unit
2025-05-20−6,500→ 0 total
Exercise/Conversion
MACROGENICS INC$MGNX
Common Stock
2025-05-20+6,500→ 44,074 total
Award
Dyne Therapeutics, Inc.$DYN
Stock option (right to buy)
2024-05-22+25,133→ 25,133 total
Award
MACROGENICS INC$MGNX
Stock Option (right to buy)
2024-05-21+16,500→ 16,500 total
Award
MACROGENICS INC$MGNX
Restricted Stock Unit
2024-05-21+6,500→ 6,500 total
Exercise/Conversion
MACROGENICS INC$MGNX
Restricted Stock Unit
2024-05-20−4,500→ 0 total
Exercise/Conversion
MACROGENICS INC$MGNX
Common Stock
2024-05-20+4,500→ 37,574 total
Purchase
MACROGENICS INC$MGNX
Common Stock
2023-08-30$4.91/sh+15,000→ 33,074 total
Award
MACROGENICS INC$MGNX
Restricted Stock Unit
2023-05-31+4,500→ 4,500 total
Award
MACROGENICS INC$MGNX
Stock Option (right to buy)
2023-05-31+19,000→ 19,000 total
Award
Dyne Therapeutics, Inc.$DYN
Stock Option (right to buy)
2023-05-24+24,900→ 24,900 total
Disposition to Issuer
APPLIED GENETIC TECHNOLOGIES CORP
Stock Option (Right to Buy)
2022-11-30−10,000→ 0 total
Disposition from Tender
APPLIED GENETIC TECHNOLOGIES CORP
Common Stock
2022-11-30−25,672→ 0 total
Disposition to Issuer
APPLIED GENETIC TECHNOLOGIES CORP
Stock Option (Right to Buy)
2022-11-30−6,200→ 0 total
Disposition to Issuer
APPLIED GENETIC TECHNOLOGIES CORP
Stock Option (Right to Buy)
2022-11-30−4,688→ 0 total
Disposition to Issuer
APPLIED GENETIC TECHNOLOGIES CORP
Stock Option (Right to Buy)
2022-11-30−8,000→ 0 total
Disposition to Issuer
APPLIED GENETIC TECHNOLOGIES CORP
Stock Option (Right to Buy)
2022-11-30−14,000→ 0 total
Disposition to Issuer
APPLIED GENETIC TECHNOLOGIES CORP
Stock Option (Right to Buy)
2022-11-30−12,000→ 0 total
Disposition from Tender
APPLIED GENETIC TECHNOLOGIES CORP
Common Stock
2022-11-30−1,800→ 0 total
Disposition to Issuer
APPLIED GENETIC TECHNOLOGIES CORP
Stock Option (Right to Buy)
2022-11-30−10,000→ 0 total
Disposition to Issuer
APPLIED GENETIC TECHNOLOGIES CORP
Stock Option (Right to Buy)
2022-11-30−10,000→ 0 total
Disposition to Issuer
APPLIED GENETIC TECHNOLOGIES CORP
Stock Option (Right to Buy)
2022-11-30−9,375→ 0 total
Award
Dyne Therapeutics, Inc.$DYN
Stock Option (right to buy)
2022-06-03+19,596→ 19,596 total
Award
MACROGENICS INC$MGNX
Stock Option (right to buy)
2022-05-19+18,000→ 18,000 total
Award
APPLIED GENETIC TECHNOLOGIES CORP
Stock Option (right to buy)
2021-11-30+14,000→ 14,000 total
Award
Dyne Therapeutics, Inc.$DYN
Stock Option (right to buy)
2021-05-26+19,596→ 19,596 total
Award
MACROGENICS INC$MGNX
Stock Option (right to buy)
2021-05-13+15,000→ 15,000 total
Award
APPLIED GENETIC TECHNOLOGIES CORP
Stock Option (right to buy)
2020-12-16+12,000→ 12,000 total
Conversion
Dyne Therapeutics, Inc.$DYN
Common Stock
2020-09-21+91,081→ 91,081 total
Conversion
Dyne Therapeutics, Inc.$DYN
Series B Preferred Stock
2020-09-21−70,492→ 0 total
Conversion
Dyne Therapeutics, Inc.$DYN
Common Stock
2020-09-21+4,614,943→ 4,614,943 total
Conversion
Dyne Therapeutics, Inc.$DYN
Series B Preferred Stock
2020-09-21−26,176→ 0 total
Conversion
Dyne Therapeutics, Inc.$DYN
Series A Preferred Stock
2020-09-21−275,932→ 0 total
Conversion
Dyne Therapeutics, Inc.$DYN
Series A Preferred Stock
2020-09-21−743,076→ 0 total
Conversion
Dyne Therapeutics, Inc.$DYN
Common Stock
2020-09-21+245,279→ 245,279 total
Conversion
Dyne Therapeutics, Inc.$DYN
Series A Preferred Stock
2020-09-21−13,980,992→ 0 total
Conversion
Dyne Therapeutics, Inc.$DYN
Series B Preferred Stock
2020-09-21−1,326,313→ 0 total
Purchase
Dyne Therapeutics, Inc.$DYN
Series B Preferred Stock
2020-08-07$2.81/sh+26,176→ 26,176 total
Purchase
Dyne Therapeutics, Inc.$DYN
Series B Preferred Stock
2020-08-07$2.81/sh+70,492→ 70,492 total
Purchase
Dyne Therapeutics, Inc.$DYN
Series B Preferred Stock
2020-08-07$2.81/sh+1,326,313→ 1,326,313 total
Purchase
Dyne Therapeutics, Inc.$DYN
Series A Preferred Stock
2020-07-31$1.00/sh+96,576→ 275,932 total
Purchase
Dyne Therapeutics, Inc.$DYN
Series A Preferred Stock
2020-07-31$1.00/sh+260,077→ 743,076 total

HURWITZ EDWARD

Recent Transactions

Companies

Recent Filings

Address